CROSS COUNTRY HEALTHCARE INC
CCRN$393M
Small CapNASDAQServices-Help Supply Services🇺🇸North AmericaBOCA RATON9.6K employees
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
7wMarket Overview
Stock performance and key metrics
CCRN News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
LAENNEC (Human Placenta Hydrolysate) IV
Chronic Liver Disease
Intradermal BCG SSI inj.
BCG Vaccination Reaction
LAENNEC (Human Placenta Hydrolysate)
Chronic Liver Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LAENNEC (Human Placenta Hydrolysate) IV | Phase 3 | Chronic Liver Disease | - | - |
Intradermal BCG SSI inj. | Phase 3 | BCG Vaccination Reaction | - | - |
LAENNEC (Human Placenta Hydrolysate) | Phase 2 | Chronic Liver Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply